PT2968159T - Gestão de osteoporose com hmw peg - Google Patents

Gestão de osteoporose com hmw peg

Info

Publication number
PT2968159T
PT2968159T PT147646715T PT14764671T PT2968159T PT 2968159 T PT2968159 T PT 2968159T PT 147646715 T PT147646715 T PT 147646715T PT 14764671 T PT14764671 T PT 14764671T PT 2968159 T PT2968159 T PT 2968159T
Authority
PT
Portugal
Prior art keywords
hmw peg
osteoporosis
managing
managing osteoporosis
hmw
Prior art date
Application number
PT147646715T
Other languages
English (en)
Portuguese (pt)
Inventor
Pamukcu Rifat
Rae Mccabe Laura
Original Assignee
Univ Michigan State
Midway Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan State, Midway Pharmaceuticals Inc filed Critical Univ Michigan State
Publication of PT2968159T publication Critical patent/PT2968159T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT147646715T 2013-03-15 2014-03-14 Gestão de osteoporose com hmw peg PT2968159T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361798481P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
PT2968159T true PT2968159T (pt) 2019-10-01

Family

ID=51537706

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147646715T PT2968159T (pt) 2013-03-15 2014-03-14 Gestão de osteoporose com hmw peg

Country Status (11)

Country Link
US (2) US10045949B2 (enExample)
EP (1) EP2968159B1 (enExample)
JP (3) JP6275239B2 (enExample)
AU (2) AU2014229082C1 (enExample)
CY (1) CY1122568T1 (enExample)
DK (1) DK2968159T3 (enExample)
ES (1) ES2744828T3 (enExample)
HU (1) HUE045032T2 (enExample)
PL (1) PL2968159T3 (enExample)
PT (1) PT2968159T (enExample)
WO (1) WO2014144425A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111419823B (zh) * 2020-04-30 2022-03-29 上海公谊药业有限公司 一种延胡索酸泰妙菌素肠溶微丸及其制备方法和用途
NL1044084B1 (nl) 2021-07-05 2023-01-11 Evers Agro B V Mestinjecteur

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10338646A (ja) * 1996-08-26 1998-12-22 Takeda Chem Ind Ltd 骨形成促進医薬組成物
ATE544354T1 (de) * 2002-11-26 2012-02-15 Univ Chicago Vermeidung und behandlung von mikrobenübertragenen epithelerkrankungen
JPWO2004105825A1 (ja) * 2003-01-10 2006-07-20 多木化学株式会社 骨形成用生体材料、該材料を含む注入用製剤、及び該材料を調製するためのキット、並びにこれらを用いる骨形成方法
JP2007533755A (ja) * 2004-04-20 2007-11-22 ザ ユニヴァーシティ オヴ シカゴ 高分子量peg様化合物を含む治療薬送達システム
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US9675696B2 (en) * 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
MX2011009988A (es) * 2009-03-23 2011-11-18 Univ Chicago Metodos para la prevencion y el tratamiento de trastornos epiteliales inducidos por radiaciones.
EP2468265A3 (en) * 2010-12-04 2013-01-02 DEEF Pharmaceutical Industries Co. Homogeneous preparations containing vitamin D

Also Published As

Publication number Publication date
EP2968159A1 (en) 2016-01-20
EP2968159B1 (en) 2019-06-12
CY1122568T1 (el) 2021-01-27
JP2016513738A (ja) 2016-05-16
JP6275239B2 (ja) 2018-02-07
US20160000730A1 (en) 2016-01-07
AU2014229082A1 (en) 2015-11-05
AU2018250501A1 (en) 2018-11-15
HUE045032T2 (hu) 2019-12-30
JP2017082009A (ja) 2017-05-18
JP6619849B2 (ja) 2019-12-11
AU2014229082C1 (en) 2019-01-17
JP2018162328A (ja) 2018-10-18
ES2744828T3 (es) 2020-02-26
DK2968159T3 (da) 2019-08-12
US10045949B2 (en) 2018-08-14
AU2018250501B2 (en) 2020-06-25
AU2014229082B2 (en) 2018-07-19
US20190015353A1 (en) 2019-01-17
PL2968159T3 (pl) 2019-11-29
WO2014144425A1 (en) 2014-09-18
EP2968159A4 (en) 2016-09-28

Similar Documents

Publication Publication Date Title
GB2522727B (en) Pulmonary delivery devices
GB2514466B (en) Display
GB201408096D0 (en) Pulmonary delivery devices
AP2016009275A0 (enExample)
BR112016011159A2 (enExample)
BR112016011272A2 (enExample)
BR102016010778A2 (enExample)
BR112014017733A2 (enExample)
BR112014017855A2 (enExample)
BR112014017901A2 (enExample)
BR112014017722A2 (enExample)
GB201308917D0 (en) Delivery
BR112014017653A2 (enExample)
BR112014017794A2 (enExample)
BR112014017601A2 (enExample)
EP2964966A4 (en) INTERMEDIATE TREE
BR112014018437A2 (enExample)
BR112014017992A2 (enExample)
GB201305118D0 (en) Blends
BR112016008577A2 (enExample)
PT2868839T (pt) Talocha
BR112016008922A2 (enExample)
HUE045032T2 (hu) Csontritkulás kezelése nagy molekulatömegû (HMW) PEG-gel
TWI562705B (en) Display
BR112016003054A2 (enExample)